Tania Schink

4.9k total citations
106 papers, 3.3k citations indexed

About

Tania Schink is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Pharmacology. According to data from OpenAlex, Tania Schink has authored 106 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cardiology and Cardiovascular Medicine, 13 papers in Epidemiology and 12 papers in Pharmacology. Recurrent topics in Tania Schink's work include Atrial Fibrillation Management and Outcomes (11 papers), Advanced MRI Techniques and Applications (9 papers) and Venous Thromboembolism Diagnosis and Management (8 papers). Tania Schink is often cited by papers focused on Atrial Fibrillation Management and Outcomes (11 papers), Advanced MRI Techniques and Applications (9 papers) and Venous Thromboembolism Diagnosis and Management (8 papers). Tania Schink collaborates with scholars based in Germany, Netherlands and Italy. Tania Schink's co-authors include Edeltraut Garbe, Marc Dewey, C. F. Dewey, Miriam Sturkenboom, Bernd Hamm, Bianca Kollhorst, Thomas Trottenberg, Andreas Kupsch, Axel Lipp and G. Arnold and has published in prestigious journals such as Annals of Internal Medicine, Gastroenterology and PLoS ONE.

In The Last Decade

Tania Schink

104 papers receiving 3.1k citations

Peers

Countries citing papers authored by Tania Schink

Since Specialization

Citations

This map shows the geographic impact of Tania Schink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tania Schink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tania Schink more than expected).

Fields of papers citing papers by Tania Schink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tania Schink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tania Schink. The network helps show where Tania Schink may publish in the future.

Co-authorship network of co-authors of Tania Schink

This figure shows the co-authorship network connecting the top 25 collaborators of Tania Schink. A scholar is included among the top collaborators of Tania Schink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tania Schink. Tania Schink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A discovery and verification approach to pharmacovigilance using electronic healthcare data 2024 ·Frontiers in Pharmacology ·Louis Dijkstra, Tania Schink, Roland Linder, Markus Schwaninger, Iris Pigeot, Marvin N. Wright, Ronja Foraita	2
2	Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countries 2024 ·PLoS ONE ·Ana Ruigómez, Tania Schink, (unknown), Ron M. C. Herings, (unknown), (unknown), Yanina Balabanova, Gunnar Brobert, Kiliana Suzart‐Woischnik, Luis A. Garcı́a Rodrı́guez	1
3	Time Trends in Patient Characteristics of New Rivaroxaban Users with Atrial Fibrillation in Germany and the Netherlands 2023 ·Drugs - Real World Outcomes ·(unknown), (unknown), Karin M. A. Swart, Yanina Balabanova, Gunnar Brobert, Kiliana Suzart‐Woischnik, Ron M. C. Herings, Tania Schink, Ulrike Haug	1
4	In atrial fibrillation epilepsy risk differs between oral anticoagulants: active comparator, nested case-control study 2023 ·EP Europace ·(unknown), Helge Müller‐Fielitz, Ronja Foraita, Matthias J. Koepp, (unknown), (unknown), Roland Linder, Iris Pigeot, Tania Schink, Markus Schwaninger	4
5	Investigating drug safety in pregnancy based on the German Pharmacoepidemiological Research Database (GePaRD): A proof‐of‐concept analysis on the association between valproate and spina bifida 2022 ·Pharmacoepidemiology and Drug Safety ·Ulrike Haug, Bianca Kollhorst, Tania Schink, Kathrin Thöne, Katarina Dathe, Christof Schaefer, (unknown)	6
6	Characterization of pregnancies exposed to St. John’s wort and their outcomes: A claims data analysis 2021 ·Reproductive Toxicology ·(unknown), (unknown), Tania Schink, Ulrike Haug	2
7	Persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment in patients with atrial fibrillation across five Western European countries 2021 ·EP Europace ·J. Komen, Anton Pottegård, Aukje K. Mantel‐Teeuwisse, Tomas Forslund, Paul Hjemdahl, Björn Wettermark, Maja Hellfritzsch, Jesper Hallas, Morten Olesen, Marion Bennie, Tanja Mueller, (unknown), Tania Schink, Ulrike Haug, Bianca Kollhorst, Øystein Karlstad, Lars J. Kjerpeseth, Olaf H. Klungel	24
8	Rationale and design of a European epidemiological post-authorization safety study (PASS) program: rivaroxaban use in routine clinical practice 2020 ·Expert Opinion on Drug Safety ·Luis A. Garcı́a Rodrı́guez, Mari‐Ann Wallander, Leif Friberg, Ana Ruigómez, Tania Schink, Irene D. Bezemer, Ron M. C. Herings, Saad Shakir, Alison Evans, (unknown), Kiliana Suzart‐Woischnik, Pareen Vora, Yanina Balabanova, Montse Soriano‐Gabarró, Gunnar Brobert	4
9	<p>Individual Antidepressants and the Risk of Fractures in Older Adults: A New User Active Comparator Study</p> 2020 ·Clinical Epidemiology ·Federica Pisa, (unknown), Bianca Kollhorst, Ulrike Haug, Tania Schink	5
10	Different Strategies to Execute Multi‐Database Studies for Medicines Surveillance in Real‐World Setting: A Reflection on the European Model 2020 ·Clinical Pharmacology & Therapeutics ·Rosa Gini, Miriam Sturkenboom, Janet Sultana, Alison Cave, Annalisa Landi, Alexandra Păcurariu, Giuseppe Roberto, Tania Schink, Gianmario Candore, Jim Slattery, Gianluca Trifirò, (unknown)	36
11	Antidepressants and the risk of death in older patients with depression: A population-based cohort study 2019 ·PLoS ONE ·Bianca Kollhorst, Kathrin Jobski, Jutta Krappweis, Tania Schink, Edeltraut Garbe, Niklas Schmedt	13
12	<p>Antidepressants and the risk of traumatic brain injury in the elderly: differences between individual agents</p> 2019 ·Clinical Epidemiology ·Federica Pisa, (unknown), Bianca Kollhorst, Ulrike Haug, Tania Schink	7
13	Antidepressant use in Denmark, Germany, Spain, and Sweden between 2009 and 2014: Incidence and comorbidities of antidepressant initiators 2019 ·Journal of Affective Disorders ·Joan Forns, Anton Pottegård, (unknown), Beatriz Poblador‐Plou, Rosa Morros, Lena Brandt, Miguel Cainzos‐Achirica, Maja Hellfritzsch, Tania Schink, Alexandra Prados‐Torres, Maria Giner‐Soriano, David Hägg, Jesper Hallas, Jordi Cortés, (unknown), (unknown), Susana Perez‐Gutthann, Manel Pladevall, Johan Reutfors	47
14	Antidepressants and the Risk of Hemorrhagic Stroke in the Elderly: a Nested Case–Control Study 2019 ·Drug Safety ·(unknown), (unknown), Bianca Kollhorst, Tania Schink	10
15	Risk of acute myocardial infarction during use of individual NSAIDs: A nested case-control study from the SOS project 2018 ·PLoS ONE ·Gwen Masclee, Huub Straatman, Andrea Arfè, Jordi Castellsagué, Edeltraut Garbe, Ron M. C. Herings, Bianca Kollhorst, S Lucchi, Susana Perez‐Gutthann, Silvana Romio, R Schade, Tania Schink, Martijn J. Schuemie, Lorenza Scotti, Cristina Varas‐Lorenzo, Vera E. Valkhoff, Marco Villa, Miriam Sturkenboom	44
16	The Risk of Ischemic Cardio- and Cerebrovascular Events Associated with Oxycodone–Naloxone and Other Extended-Release High-Potency Opioids: A Nested Case–Control Study 2017 ·Drug Safety ·Kathrin Jobski, Bianca Kollhorst, Edeltraut Garbe, Tania Schink	10
17	Population-based analysis of non-steroidal anti-inflammatory drug use among children in four European countries in the SOS project: what size of data platforms and which study designs do we need to assess safety issues? 2013 ·BMC Pediatrics ·Vera E. Valkhoff, R Schade, Geert W. ‘t Jong, Silvana Romio, Martijn J. Schuemie, Andrea Arfè, Edeltraut Garbe, Ron M. C. Herings, S Lucchi, Gino Picelli, Tania Schink, Huub Straatman, Marco Villa, Ernst J. Kuipers, Miriam Sturkenboom	29
18	Risk of upper gastrointestinal complications associated with use of individual non-steroidal anti-inflammatory drugs in the SOS Project. 2012 ·Pharmacoepidemiology and Drug Safety ·S Lucchi, (unknown), Bianca Kollhorst, Tania Schink, Edeltraut Garbe, Andrea Arfè, Jordi Castellsagué, RM Herings, (unknown), Silvana Romio, Francesco Salvo, R Schade, (unknown), Huub Straatman, Frantz Thiessard, Miriam Sturkenboom, Marco Villa	2
19	Focal Liver Lesions: SPIO-, Gadolinium-, and Ferucarbotran-enhanced Dynamic T1-weighted and Delayed T2-weighted MR Imaging in Rabbits 2006 ·Radiology ·Jörg Schnorr, Susanne Wagner, Claudia Abramjuk, Randi Drees, Tania Schink, Eyk Schellenberger, Herbert Pilgrimm, Bernd Hamm, Matthias Taupitz	21
20	Effect of Treatment with Dornase Alpha on Airway Inflammation in Patients with Cystic Fibrosis 2003 ·American Journal of Respiratory and Critical Care Medicine ·K. Paul, Ernst Rietschel, Manfred Ballmann, Matthias Griese, Dieter Worlitzsch, Janis K. Shute, (unknown), Tania Schink, Gerd Döring, Silke van Koningsbruggen, Ulrich Wahn, Félix Ratjen	139

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact